Panabyte Technologies Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 28, 2025, 9:07 am

Competitors of Panabyte Technologies Ltd

All Competitor Stocks of Panabyte Technologies Ltd

Quarterly Result

Last Updated: August 20, 2025, 5:10 am

Below is a detailed analysis of the quarterly data for Panabyte Technologies Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 1.86 Cr.. The value appears strong and on an upward trend. It has increased from 1.64 Cr. (Mar 2025) to 1.86 Cr., marking an increase of 0.22 Cr..
• For Expenses, as of Jun 2025, the value is 1.96 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.59 Cr. (Mar 2025) to 1.96 Cr., marking an increase of 0.37 Cr..
• For Operating Profit, as of Jun 2025, the value is -0.10 Cr.. The value appears to be declining and may need further review. It has decreased from 0.05 Cr. (Mar 2025) to -0.10 Cr., marking a decrease of 0.15 Cr..
• For OPM %, as of Jun 2025, the value is -5.38%. The value appears to be declining and may need further review. It has decreased from 3.05% (Mar 2025) to -5.38%, marking a decrease of 8.43%.
• For Other Income, as of Jun 2025, the value is 0.07 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.07 Cr..
• For Interest, as of Jun 2025, the value is 0.11 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.12 Cr. (Mar 2025) to 0.11 Cr., marking a decrease of 0.01 Cr..
• For Depreciation, as of Jun 2025, the value is 0.04 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.04 Cr..
• For Profit before tax, as of Jun 2025, the value is -0.18 Cr.. The value appears to be declining and may need further review. It has decreased from -0.04 Cr. (Mar 2025) to -0.18 Cr., marking a decrease of 0.14 Cr..
• For Tax %, as of Jun 2025, the value is -27.78%. The value appears to be improving (decreasing) as expected. It has decreased from -25.00% (Mar 2025) to -27.78%, marking a decrease of 2.78%.
• For Net Profit, as of Jun 2025, the value is -0.13 Cr.. The value appears to be declining and may need further review. It has decreased from -0.03 Cr. (Mar 2025) to -0.13 Cr., marking a decrease of 0.10 Cr..
• For EPS in Rs, as of Jun 2025, the value is -0.25. The value appears to be declining and may need further review. It has decreased from -0.06 (Mar 2025) to -0.25, marking a decrease of 0.19.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 4:39 am

Growth

Last Updated: September 5, 2025, 12:35 pm

Balance Sheet

Last Updated: June 16, 2025, 11:31 am

Below is a detailed analysis of the balance sheet data for Panabyte Technologies Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 5.13 Cr.. The value appears strong and on an upward trend. It has increased from 4.39 Cr. (Mar 2024) to 5.13 Cr., marking an increase of 0.74 Cr..
• For Reserves, as of Mar 2025, the value is -0.31 Cr.. The value appears to be improving (becoming less negative). It has improved from -1.90 Cr. (Mar 2024) to -0.31 Cr., marking an improvement of 1.59 Cr..
• For Borrowings, as of Mar 2025, the value is 3.58 Cr.. The value appears to be increasing, which may not be favorable. However, Reserves are negative, which is a major warning sign. It has increased from 2.97 Cr. (Mar 2024) to 3.58 Cr., marking an increase of 0.61 Cr..
• For Other Liabilities, as of Mar 2025, the value is 7.90 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.04 Cr. (Mar 2024) to 7.90 Cr., marking an increase of 1.86 Cr..
• For Total Liabilities, as of Mar 2025, the value is 16.30 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11.50 Cr. (Mar 2024) to 16.30 Cr., marking an increase of 4.80 Cr..
• For Fixed Assets, as of Mar 2025, the value is 0.52 Cr.. The value appears strong and on an upward trend. It has increased from 0.18 Cr. (Mar 2024) to 0.52 Cr., marking an increase of 0.34 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 15.78 Cr.. The value appears strong and on an upward trend. It has increased from 11.32 Cr. (Mar 2024) to 15.78 Cr., marking an increase of 4.46 Cr..
• For Total Assets, as of Mar 2025, the value is 16.30 Cr.. The value appears strong and on an upward trend. It has increased from 11.50 Cr. (Mar 2024) to 16.30 Cr., marking an increase of 4.80 Cr..

However, the Borrowings (3.58 Cr.) are higher than the Reserves (-0.31 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Panabyte Technologies Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 21, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 20) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 21, the value is -0.52. This value is below the healthy minimum of 5. It has decreased from 0.37 (Mar 20) to -0.52, marking a decrease of 0.89.
• For Diluted EPS (Rs.), as of Mar 21, the value is -0.52. This value is below the healthy minimum of 5. It has decreased from 0.37 (Mar 20) to -0.52, marking a decrease of 0.89.
• For Cash EPS (Rs.), as of Mar 21, the value is -0.47. This value is below the healthy minimum of 3. It has decreased from 0.41 (Mar 20) to -0.47, marking a decrease of 0.88.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 21, the value is 7.60. It has decreased from 7.85 (Mar 20) to 7.60, marking a decrease of 0.25.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 21, the value is 7.60. It has decreased from 7.85 (Mar 20) to 7.60, marking a decrease of 0.25.
• For Revenue From Operations / Share (Rs.), as of Mar 21, the value is 22.39. It has decreased from 34.45 (Mar 20) to 22.39, marking a decrease of 12.06.
• For PBDIT / Share (Rs.), as of Mar 21, the value is 0.23. This value is below the healthy minimum of 2. It has decreased from 0.58 (Mar 20) to 0.23, marking a decrease of 0.35.
• For PBIT / Share (Rs.), as of Mar 21, the value is 0.17. This value is within the healthy range. It has decreased from 0.53 (Mar 20) to 0.17, marking a decrease of 0.36.
• For PBT / Share (Rs.), as of Mar 21, the value is -0.61. This value is below the healthy minimum of 0. It has decreased from 0.32 (Mar 20) to -0.61, marking a decrease of 0.93.
• For Net Profit / Share (Rs.), as of Mar 21, the value is -0.53. This value is below the healthy minimum of 2. It has decreased from 0.36 (Mar 20) to -0.53, marking a decrease of 0.89.
• For NP After MI And SOA / Share (Rs.), as of Mar 21, the value is -0.53. This value is below the healthy minimum of 2. It has decreased from 0.36 (Mar 20) to -0.53, marking a decrease of 0.89.
• For PBDIT Margin (%), as of Mar 21, the value is 1.03. This value is below the healthy minimum of 10. It has decreased from 1.70 (Mar 20) to 1.03, marking a decrease of 0.67.
• For PBIT Margin (%), as of Mar 21, the value is 0.79. This value is below the healthy minimum of 10. It has decreased from 1.56 (Mar 20) to 0.79, marking a decrease of 0.77.
• For PBT Margin (%), as of Mar 21, the value is -2.75. This value is below the healthy minimum of 10. It has decreased from 0.93 (Mar 20) to -2.75, marking a decrease of 3.68.
• For Net Profit Margin (%), as of Mar 21, the value is -2.37. This value is below the healthy minimum of 5. It has decreased from 1.07 (Mar 20) to -2.37, marking a decrease of 3.44.
• For NP After MI And SOA Margin (%), as of Mar 21, the value is -2.37. This value is below the healthy minimum of 8. It has decreased from 1.07 (Mar 20) to -2.37, marking a decrease of 3.44.
• For Return on Networth / Equity (%), as of Mar 21, the value is -6.98. This value is below the healthy minimum of 15. It has decreased from 4.70 (Mar 20) to -6.98, marking a decrease of 11.68.
• For Return on Capital Employeed (%), as of Mar 21, the value is 2.14. This value is below the healthy minimum of 10. It has decreased from 6.79 (Mar 20) to 2.14, marking a decrease of 4.65.
• For Return On Assets (%), as of Mar 21, the value is -1.96. This value is below the healthy minimum of 5. It has decreased from 1.22 (Mar 20) to -1.96, marking a decrease of 3.18.
• For Long Term Debt / Equity (X), as of Mar 21, the value is 0.07. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 20) to 0.07, marking an increase of 0.07.
• For Total Debt / Equity (X), as of Mar 21, the value is 0.71. This value is within the healthy range. It has increased from 0.56 (Mar 20) to 0.71, marking an increase of 0.15.
• For Asset Turnover Ratio (%), as of Mar 21, the value is 0.78. It has decreased from 1.46 (Mar 20) to 0.78, marking a decrease of 0.68.
• For Current Ratio (X), as of Mar 21, the value is 1.41. This value is below the healthy minimum of 1.5. It has increased from 1.34 (Mar 20) to 1.41, marking an increase of 0.07.
• For Quick Ratio (X), as of Mar 21, the value is 1.09. This value is within the healthy range. It has decreased from 1.11 (Mar 20) to 1.09, marking a decrease of 0.02.
• For Dividend Payout Ratio (NP) (%), as of Mar 21, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 46.84 (Mar 20) to 0.00, marking a decrease of 46.84.
• For Dividend Payout Ratio (CP) (%), as of Mar 21, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 41.53 (Mar 20) to 0.00, marking a decrease of 41.53.
• For Earning Retention Ratio (%), as of Mar 21, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 53.16 (Mar 20) to 0.00, marking a decrease of 53.16.
• For Cash Earning Retention Ratio (%), as of Mar 21, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 58.47 (Mar 20) to 0.00, marking a decrease of 58.47.
• For Interest Coverage Ratio (X), as of Mar 21, the value is 0.45. This value is below the healthy minimum of 3. It has decreased from 4.36 (Mar 20) to 0.45, marking a decrease of 3.91.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 21, the value is 0.54. This value is below the healthy minimum of 3. It has decreased from 4.36 (Mar 20) to 0.54, marking a decrease of 3.82.
• For Enterprise Value (Cr.), as of Mar 21, the value is 8.89. It has decreased from 11.17 (Mar 20) to 8.89, marking a decrease of 2.28.
• For EV / Net Operating Revenue (X), as of Mar 21, the value is 0.90. This value is below the healthy minimum of 1. It has increased from 0.73 (Mar 20) to 0.90, marking an increase of 0.17.
• For EV / EBITDA (X), as of Mar 21, the value is 87.36. This value exceeds the healthy maximum of 15. It has increased from 43.40 (Mar 20) to 87.36, marking an increase of 43.96.
• For MarketCap / Net Operating Revenue (X), as of Mar 21, the value is 0.66. This value is below the healthy minimum of 1. It has increased from 0.61 (Mar 20) to 0.66, marking an increase of 0.05.
• For Retention Ratios (%), as of Mar 21, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 53.15 (Mar 20) to 0.00, marking a decrease of 53.15.
• For Price / BV (X), as of Mar 21, the value is 1.95. This value is within the healthy range. It has decreased from 2.69 (Mar 20) to 1.95, marking a decrease of 0.74.
• For Price / Net Operating Revenue (X), as of Mar 21, the value is 0.66. This value is below the healthy minimum of 1. It has increased from 0.61 (Mar 20) to 0.66, marking an increase of 0.05.
• For EarningsYield, as of Mar 21, the value is -0.03. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 20) to -0.03, marking a decrease of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness